Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

stereotactic

stereotactic is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 1
Pipeline programs 9
News articles 0
Drug details — stereotactic
Class
—
Route
—
Patents
1
Programs
9
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

stereotactic is an FDA-listed pharmaceutical active ingredient.

Key facts

INN stereotactic

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Stereotactic Radiation Therapy Phase 3 · GT Biopharma · Brain Metastases
  2. ZOSTER ICO-N-2018-14 Phase 3 · CERo Therapeutics · Patients, men or women over 18 old, with inoperable vertebra
  3. ICO-2020-01 REPAIR Phase 2 · CERo Therapeutics · RElapse in previously irradiated Prostate bed
  4. SBRT combined with PD-1 inhibitors and thoracic hyperthermia Phase 2 · First People's Hospital · Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperth
  5. Safety and efficacy of IMM-101 combined with... Phase 2 · Disc Medicine · Limited metastatic pancreatic cancer
  6. Stereotactic Radiation Therapy Approved · GT Biopharma · Glioblastoma
  7. Stereotactic body radiotherapy (SBRT) Unknown · Chinese Academy of · HSCT
  8. stereotactic body radiotherapy Unknown · Chinese Academy of · Prostate Cancer

Related patents

Browse patents

  1. US 12420113

    Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is stereotactic?

stereotactic is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.